Found: 3
Select item for more details and to access through your institution.
Later-Line Treatment with Lorlatinib in ALK - and ROS1 -Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 371, doi. 10.3390/ph13110371
- By:
- Publication type:
- Article
New insights from GINA 2019/2020—Focus on early anti-inflammatory therapy.
- Published in:
- 2021
- By:
- Publication type:
- Letter
The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry.
- Published in:
- Respiratory Research, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12931-023-02338-0
- By:
- Publication type:
- Article